AMNEAL 506 (Indomethacin extended release 75 mg)

Pill imprint AMNEAL 506 has been identified as Indomethacin extended release 75 mg.

Indomethacin is used in the treatment of gout, acute; back pain; pain; ankylosing spondylitis; cluster headaches (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 75 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for AMNEAL 506

Indomethacin extended release 75 mg AMNEAL 506
Indomethacin extended release 75 mg AMNEAL 506
Indomethacin extended release 75 mg AMNEAL 506
Indomethacin extended release
Imprint:
AMNEAL
506
Strength:
75 mg
Color:
Blue / Clear
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Amneal Pharmaceuticals
National Drug Code (NDC):
65162-0506
Inactive Ingredients:
ammonia
ferrosoferric oxide
butyl alcohol
corn starch
alcohol
FD&C Blue No. 1
FD&C Green No. 3
FD&C Yellow No. 5
FD&C Red No. 40
gelatin
isopropyl alcohol
lactose monohydrate
potassium hydroxide
povidone
propylene glycol
shellac
sucrose
magnesium silicate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)